Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

March’s top stories: Tracon’s Phase IbTRC105 clinical trial, ADC begins ADCT-402 trial

Tracon Pharmaceuticals started Phase Ib clinical trial of TRC105, a clinical stage antibody to endoglin, and ADC Therapeutics began a Phase I trial of its antibody drug conjugate (ADC) ADCT-402. Drugdevelopment-technology.com wraps-up the key headlines from March 2016.

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free


Go Top